 | | | | Related Healthscout Videos | |
|
WEDNESDAY, Oct. 1 (HealthDay News) -- U.S. health officials are giving nearly $3 million to the American Hospital Association to help reduce so-called central line-associated bloodstream infections in hospital intensive care units.
Each year, an estimated 250,000 intensive care unit (ICU) patients suffer these infections, and 30,000 to 62,000 of them die, according to the U.S. Centers for Diseases Control and Prevention. The grant from the U.S. Agency for Healthcare Research and Quality (AHRQ) will be used over three years to roll out a program designed to reduce these infections nationwide.
Text Continues Below
"When we go to a hospital, we expect to leave healthier, not sicker," Dr. Carolyn M. Clancy, AHRQ's director, said during a Wednesday teleconference. "Unfortunately, it does not always work out that way. Too often, care provided in a hospital leads to infection. These infections are among the greatest risk that patients face."
These infections are largely preventable, Clancy said. "We are simply not doing nearly enough to prevent them. Changing behavior in health-care settings is challenging and isn't as simple as handing clinicians a checklist," she said.
Although infections occur in other parts of hospitals, concentrating on the ICU is a first step in trying to bring down infection rates throughout hospitals, Dr. Peter J. Pronovost, a professor at Johns Hopkins University School of Medicine, said during the teleconference.
The program was started by Johns Hopkins University in Baltimore and the Michigan Health & Hospital Association. It's designed to be a comprehensive unit-based patient safety program to help prevent infections related to central line catheters. Central line catheters, also called central venous catheters, are tubes placed into a large vein in the neck, chest or groin to supply medications or fluids or to collect blood samples.
Page: 1 | 2 | Next >>
|
.gif)
